Tributary Capital Management’s Amgen AMGN Stock Holding History

Tributary Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,605	Closed	-$565K	–	137
2026 Q1	$565K	Sell	1,605 -30	-2%	-$10.7K	0.05%	112
2025 Q4	$535K	Sell	1,635 -55	-3%	-$17.4K	0.05%	118
2025 Q3	$477K	Sell	1,690 -80	-5%	-$23.2K	0.04%	129
2025 Q2	$494K	Sell	1,770 -60	-3%	-$17K	0.04%	125
2025 Q1	$570K	Sell	1,830 -69	-4%	-$20.4K	0.05%	115
2024 Q4	$495K	Sell	1,899 -99	-5%	-$29.4K	0.04%	119
2024 Q3	$644K	Sell	1,998 -65	-3%	-$21.3K	0.05%	103
2024 Q2	$645K	Sell	2,063 -110	-5%	-$32.3K	0.05%	110
2024 Q1	$618K	Buy	2,173 +510	+31%	+$149K	0.05%	115
2023 Q4	$479K	Buy	+1,663	New	+$453K	0.04%	134

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Tributary Capital Management's AMGN Position: Q2 2026 in Review

Tributary Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,605 shares — an estimated $565K sold.

Tributary Capital Management first reported a position in AMGN in Q4 2023 and held it in 10 quarters. The position peaked at $645K in Q2 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Tributary Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Tributary Capital Management sold 1,605 Amgen shares in Q2 2026, an estimated $565K.
Tributary Capital Management first reported a position in Amgen in Q4 2023 and held it in 10 quarters.
Tributary Capital Management's Amgen position peaked at $645K in Q2 2024.
1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tributary Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.